483 Novosource Mar 2014

483 Novosource Mar 2014

Allison Mcgloin FDA$119.00 - Available Now

FDA investigators audited the Novosource - Dayton, OH, United States facility and issued 3 inspectional observations (via FDA 483) on 28 Mar 2014.

Product details

  • Category: Medical Devices & Rad Health
  • Number of Observations: 3
  • Inspection end: 28 Mar 2014
  • Location: Dayton, United States
  • FEI: 3009946696
Add To Cart